The NKCC1 inhibitor bumetanide has no discernible effect on plasma cell survival, persistence or antibody secretion
Freeda DSouza, David Mathew Tarlinton, Zhoujie Ding, Marcus J Robinson
This study shows that inhibiting NKCC1 with bumetanide does not affect plasma cell survival, persistence, or antibody secretion in vitro and in vivo.
bioRxiv · May 26, 2026 · PreprintImmunology